Journal article · 2022 · Open access

Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival

Mariana Ribeiro Monteiro, N.C.C. Nunes, J. Crespo, Ana Beatriz Kinupe Abrahão, Gustavo Buscacio, Lilian Campos Caldeira Lerner, Letícia Morais C. O. Sermoud, Renata Arakelian, Gustavo Henrique Munhoz Piotto, C. Lemos, R. Campos, D. Victorino and 6 more

Clinical Oncology, 34(9), 608–616 · Published 3 June 2022 · DOI 10.1016/j.clon.2022.05.015

Open full textCite this paper

In brief

“Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival” is a 2022 journal article by Mariana Ribeiro Monteiro and 17 co-authors, published in Clinical Oncology. OpenAlex counts 18 citations as of 22 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Clinical Oncology.

Citations
18
Most cited in
2025 (6)
Field-weighted impact
1.32
References
23
Authors
18

Abstract

AIMS: In recent years, major improvements in breast cancer treatments have led to a significant increase in survival. Despite that, this population's quality of life (QoL) information is lacking, especially real-world data. MATERIALS AND METHODS: This was a prospective, multicentre, observational study of female breast cancer patients, without prior systemic treatment, treated between 2012 and 2019 in private health care in Brazil. QoL was assessed by two questionnaires, the EQ-5D-5L and the EORTC-QLQ-BR23. Additional data were retrospectively collected. RESULTS: The study comprised 1372 patients, most with early-stage disease (80.2% stages 0-II). At a median follow-up of 25.6 months, the estimated 3-year overall survival was 93.6%. Patients with locally advanced and metastatic breast cancer had the lowest visual analogue scale scores and the highest symptom burden in all dimensions of EQ-5D-5L, but with the most significant improvement after treatment. With the EORTC-QLQ-BR23 questionnaire, patients undergoing lumpectomy had a better perception of body image. Axillary dissection led to greater arm symptoms after 12 months, radiotherapy enhanced breast symptoms and patients treated with chemotherapy had significant worsening in the effects of systemic therapy compared with endocrine or HER2 therapy. Staging and immunohistochemical subtype correlated with survival and with several QoL parameters, but overall survival was not independently affected by patient-reported outcomes in this cohort. CONCLUSION: Our results show that early diagnosis and access to treatments with fewer side-effects, such as endocrine or targeted therapy, and less aggressive surgeries are the best strategies to achieve a better QoL for breast cancer patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Monteiro, M. R., Nunes, N., Crespo, J., Abrahão, A. B. K., Buscacio, G., Lerner, L. C. C., Sermoud, L. M. C. O., Arakelian, R., Piotto, G. H. M., Lemos, C., Campos, R., Victorino, D., Andrade, P., Ferreira, T., Pecoraro, J. P., Meton, F., Gaui, M., & Araujo, L. H. (2022). Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival. Clinical Oncology, 34(9), 608–616. https://doi.org/10.1016/j.clon.2022.05.015

MLA 9

Monteiro, Mariana Ribeiro, et al. “Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival.” Clinical Oncology, vol. 34, no. 9, 2022, pp. 608–616. https://doi.org/10.1016/j.clon.2022.05.015.

Chicago

Monteiro, Mariana Ribeiro, N.C.C. Nunes, J. Crespo, Ana Beatriz Kinupe Abrahão, Gustavo Buscacio, Lilian Campos Caldeira Lerner, Letícia Morais C. O. Sermoud, et al. 2022. “Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival.” Clinical Oncology 34 (9): 608–616. https://doi.org/10.1016/j.clon.2022.05.015.

Harvard

Monteiro, M. R. et al. (2022) ‘Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival’, Clinical Oncology, 34(9), pp. 608–616. doi:10.1016/j.clon.2022.05.015.

IEEE

M. R. Monteiro et al., “Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival,” Clinical Oncology, vol. 34, no. 9, pp. 608–616, 2022, doi: 10.1016/j.clon.2022.05.015.

BibTeX

@article{monteiro2022patient,
  title     = {{Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival}},
  author    = {Monteiro, Mariana Ribeiro and Nunes, N.C.C. and Crespo, J. and Abrahão, Ana Beatriz Kinupe and Buscacio, Gustavo and Lerner, Lilian Campos Caldeira and Sermoud, Letícia Morais C. O. and Arakelian, Renata and Piotto, Gustavo Henrique Munhoz and Lemos, C. and Campos, R. and Victorino, D. and Andrade, Perla and Ferreira, Thamirez and Pecoraro, Juliana Pompeu and Meton, F. and Gaui, M.F. and Araujo, Luiz Henrique},
  journal   = {Clinical Oncology},
  year      = {2022},
  volume    = {34},
  number    = {9},
  pages     = {608--616},
  doi       = {10.1016/j.clon.2022.05.015},
  url       = {https://doi.org/10.1016/j.clon.2022.05.015}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202333
202444
202566
202611

Its field-weighted citation impact is 1.32: it has been cited 1.32 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • breast cancer
  • quality of life
  • patient-reported outcomes
  • EQ-5D-5L
  • EORTC QLQ-BR23
  • overall survival
  • early breast cancer
  • body image

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Monteiro, M. R., Nunes, N., Crespo, J., Abrahão, A. B. K., Buscacio, G., Lerner, L. C. C., Sermoud, L. M. C. O., Arakelian, R., Piotto, G. H. M., Lemos, C., Campos, R., Victorino, D., Andrade, P., Ferreira, T., Pecoraro, J. P., Meton, F., Gaui, M., & Araujo, L. H. (2022). Patient-centered Outcomes in Breast Cancer: Description of EQ-5D-5L and EORTC-QLQ-BR23 Measurements in Real-world Data and Their Association With Survival. Clinical Oncology, 34(9), 608–616. https://doi.org/10.1016/j.clon.2022.05.015

How many times has this paper been cited?

18 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Oncology: sign in and open the full text from this page.

Who wrote this paper?

Mariana Ribeiro Monteiro, N.C.C. Nunes, J. Crespo, Ana Beatriz Kinupe Abrahão, Gustavo Buscacio, Lilian Campos Caldeira Lerner, Letícia Morais C. O. Sermoud, Renata Arakelian, Gustavo Henrique Munhoz Piotto, C. Lemos, R. Campos, D. Victorino and 6 more.

What is the DOI of this paper?

10.1016/j.clon.2022.05.015, permanently at https://doi.org/10.1016/j.clon.2022.05.015. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.